Aging and Parkinson's Disease: Different Sides of the Same Coin?

Overview

Journal Mov Disord

Date 2017 May 19

PMID 28520211

Citations 116

Authors

Timothy J Collier

Nicholas M Kanaan

Jeffrey H Kordower

Affiliations

Soon will be listed here.

Abstract

Despite abundant epidemiological evidence in support of aging as the primary risk factor for PD, biological correlates of a connection have been elusive. In this article, we address the following question: does aging represent biology accurately characterized as pre-PD? We present evidence from our work on midbrain dopamine neurons of aging nonhuman primates that demonstrates that markers of known correlates of dopamine neuron degeneration in PD, including impaired proteasome/lysosome function, oxidative/nitrative damage, and inflammation, all increase with advancing age and are exaggerated in the ventral tier substantia nigra dopamine neurons most vulnerable to degeneration in PD. Our findings support the view that aging-related changes in the dopamine system approach the biological threshold for parkinsonism, actively producing a vulnerable pre-parkinsonian state. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

Citing Articles

Longitudinal multi-omics in alpha-synuclein Drosophila model discriminates disease- from age-associated pathologies in Parkinson's disease.

Moore J, Wu T, Dhindsa J, El Fadel O, Le A, Perez A NPJ Parkinsons Dis. 2025; 11(1):46.

PMID: 40069190 PMC: 11897226. DOI: 10.1038/s41531-025-00899-z.

Temporal Trends in Parkinson's Disease Related Mortality from 1999-2020: A National Analysis.

Sokhal B, Prasanna Kumar Menon S, Shepherd T, Muller S, Arora A, Mallen C NIHR Open Res. 2025; 4():50.

PMID: 39830305 PMC: 11739699. DOI: 10.3310/nihropenres.13623.1.

The centenarian blueprint: lessons in defying Parkinson's disease.

Bhidayasiri R, Aiba I, Nomoto M J Neural Transm (Vienna). 2024; 132(3):331-339.

PMID: 39729254 DOI: 10.1007/s00702-024-02875-y.

Assessing age-related changes in brain activity during isometric upper and lower limb force control tasks.

Bower A, Chung J, Burciu R Brain Struct Funct. 2024; 230(1):6.

PMID: 39688714 PMC: 11652581. DOI: 10.1007/s00429-024-02866-5.

Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond.

Perdaens O, van Pesch V Int J Mol Sci. 2024; 25(23.

PMID: 39684351 PMC: 11641818. DOI: 10.3390/ijms252312637.

References

Durcan T, Fon E . The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications. Genes Dev. 2015; 29(10):989-99. PMC: 4441056. DOI: 10.1101/gad.262758.115. View

Chu Y, Dodiya H, Aebischer P, Olanow C, Kordower J . Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions. Neurobiol Dis. 2009; 35(3):385-98. DOI: 10.1016/j.nbd.2009.05.023. View

Stark A, Pakkenberg B . Histological changes of the dopaminergic nigrostriatal system in aging. Cell Tissue Res. 2004; 318(1):81-92. DOI: 10.1007/s00441-004-0972-9. View

Chu Y, Le W, Kompoliti K, Jankovic J, Mufson E, Kordower J . Nurr1 in Parkinson's disease and related disorders. J Comp Neurol. 2005; 494(3):495-514. PMC: 2564615. DOI: 10.1002/cne.20828. View

Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R . A C. elegans mutant that lives twice as long as wild type. Nature. 1993; 366(6454):461-4. DOI: 10.1038/366461a0. View

Gibb W, Lees A . Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1991; 54(5):388-96. PMC: 488535. DOI: 10.1136/jnnp.54.5.388. View

Hely M, Morris J, Reid W, OSullivan D, Williamson P, Broe G . Age at onset: the major determinant of outcome in Parkinson's disease. Acta Neurol Scand. 1995; 92(6):455-63. DOI: 10.1111/j.1600-0404.1995.tb00480.x. View

Olanow C, Kordower J . Modeling Parkinson's disease. Ann Neurol. 2009; 66(4):432-6. DOI: 10.1002/ana.21832. View

Seidler R, Bernard J, Burutolu T, Fling B, Gordon M, Gwin J . Motor control and aging: links to age-related brain structural, functional, and biochemical effects. Neurosci Biobehav Rev. 2009; 34(5):721-33. PMC: 2838968. DOI: 10.1016/j.neubiorev.2009.10.005. View

10.

Polymeropoulos M, Lavedan C, Leroy E, Ide S, Dehejia A, Dutra A . Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997; 276(5321):2045-7. DOI: 10.1126/science.276.5321.2045. View

11.

Goldman J, Yen S, Chiu F, Peress N . Lewy bodies of Parkinson's disease contain neurofilament antigens. Science. 1983; 221(4615):1082-4. DOI: 10.1126/science.6308771. View

12.

Irwin I, DELANNEY L, McNeill T, Chan P, FORNO L, Murphy Jr G . Aging and the nigrostriatal dopamine system: a non-human primate study. Neurodegeneration. 1994; 3(4):251-65. View

13.

Collier T, Dung Ling Z, Carvey P, Fletcher-Turner A, Yurek D, Sladek Jr J . Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism. Exp Neurol. 2005; 191 Suppl 1:S60-7. DOI: 10.1016/j.expneurol.2004.08.018. View

14.

Pakkenberg H, Andersen B, Burns R, Pakkenberg B . A stereological study of substantia nigra in young and old rhesus monkeys. Brain Res. 1995; 693(1-2):201-6. DOI: 10.1016/0006-8993(95)00678-j. View

15.

Singleton A, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J . alpha-Synuclein locus triplication causes Parkinson's disease. Science. 2003; 302(5646):841. DOI: 10.1126/science.1090278. View

16.

Dexter D, Carter C, WELLS F, Agid Y, Lees A, Jenner P . Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem. 1989; 52(2):381-9. DOI: 10.1111/j.1471-4159.1989.tb09133.x. View

17.

Ibanez P, Bonnet A, Debarges B, Lohmann E, Tison F, Pollak P . Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet. 2004; 364(9440):1169-71. DOI: 10.1016/S0140-6736(04)17104-3. View

18.

Pringsheim T, Jette N, Frolkis A, Steeves T . The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014; 29(13):1583-90. DOI: 10.1002/mds.25945. View

19.

Ling Z, Collier T, Sortwell C, Lipton J, Vu T, Robie H . Striatal trophic activity is reduced in the aged rat brain. Brain Res. 2000; 856(1-2):301-9. DOI: 10.1016/s0006-8993(00)01945-4. View

20.

Kordower J, Goetz C, Chu Y, Halliday G, Nicholson D, Musial T . Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient. Ann Neurol. 2016; 81(1):46-57. PMC: 5890810. DOI: 10.1002/ana.24820. View